News Daily News NT-proBNP Level Helps ID Patients Who Won't Benefit From TAVR Todd Neale November 30, 2020
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Daily News US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends Caitlin E. Cox November 17, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2020 Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves Todd Neale October 17, 2020
Presentation TCT 2020 TRANSIT: Treatment of Failed TAVR With TAVR Presenter: Luca Testa October 17, 2020
News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
Presentation TCT 2020 Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry Presenter: David Cohen October 16, 2020
News Conference News TCT 2020 Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains Todd Neale October 16, 2020
Presentation TCT 2020 SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results Presenter: Hans-Josef Feistritzer October 16, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TCT 2020 Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II Todd Neale October 15, 2020
Presentation TCT 2020 Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial Presenter: Corrado Tamburino October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020